GATA2 deficiency and related myeloid neoplasms

Seminars in Hematology

Volumn 54, Issue 2, 2017, Pages 81-86

  Wlodarski, Marcin W ^a,b   Collin, Matthew ^c   Horwitz, Marshall S ^d  

^a UNIVERSITY OF FREIBURG   (Germany)

^b GERMAN CANCER RESEARCH CENTER DKFZ   (Germany)

^c NEWCASTLE UPON TYNE HOSPITALS NHS FOUNDATION TRUST   (United Kingdom)

^d UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

Author keywords

Bone marrow failure; Emberger syndrome; Familial MDS; GATA2 deficiency; Genetic predisposition; MonoMAC; Monosomy 7

Indexed keywords

TRANSCRIPTION FACTOR GATA 2;

ACUTE MYELOID LEUKEMIA; ARTICLE; ASXL1 GENE; B LYMPHOCYTE; CANCER PROGNOSIS; CD4+ T LYMPHOCYTE; CHRONIC MYELOMONOCYTIC LEUKEMIA; CLINICAL FEATURE; CLONAL EVOLUTION; CONGENITAL DEAFNESS; DENDRITIC CELL; GATA2 GENE; GENE; GENE MUTATION; GENETIC ASSOCIATION; GENETIC PREDISPOSITION; HEMATOLOGIC DISEASE; HUMAN; IMMUNOPATHOLOGY; LYMPHEDEMA; MALIGNANT TRANSFORMATION; MISSENSE MUTATION; MONOCYTE; MONOSOMY 7; MYELOPROLIFERATIVE NEOPLASM; NATURAL KILLER CELL; NONHUMAN; PRIORITY JOURNAL; SETBP1 GENE; TRISOMY 8; DEFICIENCY; GENETICS; MYELOPROLIFERATIVE DISORDER;

GATA2 TRANSCRIPTION FACTOR; GENETIC PREDISPOSITION TO DISEASE; HEMATOLOGIC NEOPLASMS; HUMANS; MYELOPROLIFERATIVE DISORDERS;

EID: 85019945356     PISSN: 00371963     EISSN: 15328686     Source Type: Journal    
DOI: 10.1053/j.seminhematol.2017.05.002     Document Type: Article

References (70)

1. Bigley, V., Collin, M., Dendritic cell, monocyte, B and NK lymphoid deficiency defines the lost lineages of a new GATA-2 dependent myelodysplastic syndrome. Haematologica 96:8 (2011), 1081–1083.
2. Bigley, V., Haniffa, M., Doulatov, S., et al. The human syndrome of dendritic cell, monocyte, B and NK lymphoid deficiency. J Exp Med 208:2 (2011), 227–234.
3. Dickinson, R.E., Griffin, H., Bigley, V., et al. Exome sequencing identifies GATA-2 mutation as the cause of dendritic cell, monocyte, B and NK lymphoid deficiency. Blood 118:10 (2011), 2656–2658.
4. Hsu, A.P., Sampaio, E.P., Khan, J., et al. Mutations in GATA2 are associated with the autosomal dominant and sporadic monocytopenia and mycobacterial infection (MonoMAC) syndrome. Blood 118:10 (2011), 2653–2655.
5. Mansour, S., Connell, F., Steward, C., et al. Emberger syndrome-primary lymphedema with myelodysplasia: report of seven new cases. Am J Med Genet A 152A:9 (2010), 2287–2296.
6. Ostergaard, P., Simpson, M.A., Connell, F.C., et al. Mutations in GATA2 cause primary lymphedema associated with a predisposition to acute myeloid leukemia (Emberger syndrome). Nat Genet 43:10 (2011), 929–931.
7. Hahn, C.N., Chong, C.E., Carmichael, C.L., et al. Heritable GATA2 mutations associated with familial myelodysplastic syndrome and acute myeloid leukemia. Nat Genet 43:10 (2011), 1012–1017.
8. Wlodarski, M.W., Hirabayashi, S., Pastor, V., et al. Prevalence, clinical characteristics, and prognosis of GATA2-related myelodysplastic syndromes in children and adolescents. Blood 127:11 (2016), 1387–1397.
9. Pasquet, M., Bellanne-Chantelot, C., Tavitian, S., et al. High frequency of GATA2 mutations in patients with mild chronic neutropenia evolving to MonoMac syndrome, myelodysplasia, and acute myeloid leukemia. Blood 121:5 (2013), 822–829.
10. Collin, M., Dickinson, R., Bigley, V., Haematopoietic and immune defects associated with GATA2 mutation. Br J Haematol 169:2 (2015), 173–187.
11. Dickinson, R.E., Milne, P., Jardine, L., et al. The evolution of cellular deficiency in GATA2 mutation. Blood 123:6 (2014), 863–874.
12. Spinner, M.A., Sanchez, L.A., Hsu, A.P., et al. GATA2 deficiency: a protean disorder of hematopoiesis, lymphatics, and immunity. Blood 123:6 (2014), 809–821.
13. Orkin, S.H., Gata-binding transcription factors in hematopoietic-cells. Blood 80:3 (1992), 575–581.
14. Laverriere, A.C., MacNeill, C., Mueller, C., Poelmann, R.E., Burch, J.B., Evans, T., GATA-4/5/6, a subfamily of three transcription factors transcribed in developing heart and gut. J Biol Chem 269:37 (1994), 23177–23184.
15. Dorfman, D.M., Wilson, D.B., Bruns, G.A., Orkin, S.H., Human transcription factor GATA-2. Evidence for regulation of preproendothelin-1 gene expression in endothelial cells. J Biol Chem 267:2 (1992), 1279–1285.
16. Wieser, R., Volz, A., Vinatzer, U., et al. Transcription factor GATA-2 gene is located near 3q21 breakpoints in myeloid leukemia. Biochem Biophys Res Commun 273:1 (2000), 239–245.
17. Pan, X., Minegishi, N., Harigae, H., et al. Identification of human GATA-2 gene distal IS exon and its expression in hematopoietic stem cell fractions. J Biochem 127:1 (2000), 105–112.
18. Minegishi, N., Suzuki, N., Yokomizo, T., et al. Expression and domain-specific function of GATA-2 during differentiation of the hematopoietic precursor cells in midgestation mouse embryos. Blood 102:3 (2003), 896–905.
19. Viger, R.S., Guittot, S.M., Anttonen, M., Wilson, D.B., Heikinheimo, M., Role of the GATA family of transcription factors in endocrine development, function, and disease. Mol Endocrinol 22:4 (2008), 781–798.
20. Tsai, F.Y., Orkin, S.H., Transcription factor GATA-2 is required for proliferation/survival of early hematopoietic cells and mast cell formation, but not for erythroid and myeloid terminal differentiation. Blood 89:10 (1997), 3636–3643.
21. Tsai, F.Y., Keller, G., Kuo, F.C., et al. An early haematopoietic defect in mice lacking the transcription factor GATA-2. Nature 371:6494 (1994), 221–226.
22. Minegishi, N., Ohta, J., Yamagiwa, H., et al. The mouse GATA-2 gene is expressed in the para-aortic splanchnopleura and aorta-gonads and mesonephros region. Blood 93:12 (1999), 4196–4207.
23. Ng, Y.K., George, K.M., Engel, J.D., Linzer, D.I., GATA factor activity is required for the trophoblast-specific transcriptional regulation of the mouse placental lactogen I gene. Development 120:11 (1994), 3257–3266.
24. Nardelli, J., Thiesson, D., Fujiwara, Y., Tsai, F.Y., Orkin, S.H., Expression and genetic interaction of transcription factors GATA-2 and GATA-3 during development of the mouse central nervous system. Dev Biol 210:2 (1999), 305–321.
25. Martowicz, M.L., Grass, J.A., Boyer, M.E., Guend, H., Bresnick, E.H., Dynamic GATA factor interplay at a multicomponent regulatory region of the GATA-2 locus. J Biol Chem 280:3 (2005), 1724–1732.
26. Grass, J.A., Jing, H., Kim, S.-I., et al. Distinct functions of dispersed GATA factor complexes at an endogenous gene locus. Mol Cell Biol 26:19 (2006), 7056–7067.
27. Snow, J.W., Trowbridge, J.J., Fujiwara, T., et al. A single cis element maintains repression of the key developmental regulator Gata2. PLoS Genet, 6(9), 2010, e1001103.
28. Suzuki, M., Kobayashi-Osaki, M., Tsutsumi, S., et al. GATA factor switching from GATA2 to GATA1 contributes to erythroid differentiation. Genes Cells 18:11 (2013), 921–933.
29. Gao, X., Johnson, K.D., Chang, Y.-I., et al. Gata2 cis-element is required for hematopoietic stem cell generation in the mammalian embryo. J Exp Med 210:13 (2013), 2833–2842.
30. Shimamoto, T., Ohyashiki, K., Ohyashiki, J.H., et al. The expression pattern of erythrocyte/megakaryocyte-related transcription factors GATA-1 and the stem cell leukemia gene correlates with hematopoietic differentiation and is associated with outcome of acute myeloid leukemia. Blood 86:8 (1995), 3173–3180.
31. Vicente, C., Vazquez, I., Conchillo, A., et al. Overexpression of GATA2 predicts an adverse prognosis for patients with acute myeloid leukemia and it is associated with distinct molecular abnormalities. Leukemia 26:3 (2012), 550–554.
32. Fasan, A., Eder, C., Haferlach, C., et al. GATA2 mutations are frequent in intermediate-risk karyotype AML with biallelic CEBPA mutations and are associated with favorable prognosis. Leukemia 27:2 (2013), 482–485.
33. Greif, P.A., Dufour, A., Konstandin, N.P., et al. GATA2 zinc finger 1 mutations associated with biallelic CEBPA mutations define a unique genetic entity of acute myeloid leukemia. Blood 120:2 (2012), 395–403.
34. Zhang, S.J., Shi, J.Y., Li, J.Y., GATA-2 L359 V mutation is exclusively associated with CML progression but not other hematological malignancies and GATA-2 P250A is a novel single nucleotide polymorphism. Leuk Res 33:8 (2009), 1141–1143.
35. Groschel, S., Sanders, M.A., Hoogenboezem, R., et al. A single oncogenic enhancer rearrangement causes concomitant EVI1 and GATA2 deregulation in leukemia. Cell 157:2 (2014), 369–381.
36. Yamazaki, H., Suzuki, M., Otsuki, A., et al. A remote GATA2 hematopoietic enhancer drives leukemogenesis in inv(3)(q21;q26) by activating EVI1 expression. Cancer Cell 25:4 (2014), 415–427.
37. Rodrigues, N.P., Janzen, V., Forkert, R., et al. Haploinsufficiency of GATA-2 perturbs adult hematopoietic stem-cell homeostasis. Blood 106:2 (2005), 477–484.
38. Ling, K.W., Ottersbach, K., van Hamburg, J.P., et al. GATA-2 plays two functionally distinct roles during the ontogeny of hematopoietic stem cells. J Exp Med 200:7 (2004), 871–882.
39. Kazenwadel, J., Secker, G.A., Liu, Y.J., et al. Loss-of-function germline GATA2 mutations in patients with MDS/AML or MonoMAC syndrome and primary lymphedema reveal a key role for GATA2 in the lymphatic vasculature. Blood 119:5 (2012), 1283–1291.
40. Calvo, K.R., Vinh, D.C., Maric, I., et al. Myelodysplasia in autosomal dominant and sporadic monocytopenia immunodeficiency syndrome: diagnostic features and clinical implications. Haematologica 96:8 (2011), 1221–1225.
41. Ganapathi, K.A., Townsley, D.M., Hsu, A.P., et al. GATA2 deficiency-associated bone marrow disorder differs from idiopathic aplastic anemia. Blood 125:1 (2015), 56–70.
42. Mir, M.A., Kochuparambil, S.T., Abraham, R.S., et al. Spectrum of myeloid neoplasms and immune deficiency associated with germline GATA2 mutations. Cancer Med 4:4 (2015), 490–499.
43. Novakova, M., Zaliova, M., Sukova, M., et al. Loss of B cells and their precursors is the most constant feature of GATA-2 deficiency in childhood myelodysplastic syndrome. Haematologica 101:6 (2016), 707–716.
44. Horwitz, M.S., GATA2 deficiency: flesh and blood. Blood 123:6 (2014), 799–800.
45. Holme, H., Hossain, U., Kirwan, M., Walne, A., Vulliamy, T., Dokal, I., Marked genetic heterogeneity in familial myelodysplasia/acute myeloid leukaemia. Br J Haematol 158:2 (2012), 242–248.
46. Zhang, M.Y., Keel, S.B., Walsh, T., et al. Genomic analysis of bone marrow failure and myelodysplastic syndromes reveals phenotypic and diagnostic complexity. Haematologica 100:1 (2015), 42–48.
47. Bodor, C., Renneville, A., Smith, M., et al. Germ-line GATA2 p.THR354MET mutation in familial myelodysplastic syndrome with acquired monosomy 7 and ASXL1 mutation demonstrating rapid onset and poor survival. Haematol. Hematol J 97:6 (2012), 890–894.
48. Hsu, A.P., Johnson, K.D., Falcone, E.L., et al. GATA2 haploinsufficiency caused by mutations in a conserved intronic element leads to MonoMAC syndrome. Blood 121:19 (2013), 3830–3837.
49. Schlums, H., Jung, M., Han, H., et al. Adaptive NK cells can persist in patients with GATA2 mutation depleted of stem and progenitor cells. Blood 129:14 (2017), 1927–1939.
50. West, R.R., Hsu, A.P., Holland, S.M., Cuellar-Rodriguez, J., Hickstein, D.D., Acquired ASXL1 mutations are common in patients with inherited GATA2 mutations and correlate with myeloid transformation. Haematologica 99:2 (2014), 276–281.
51. Wang, X.A., Muramatsu, H., Okuno, Y., et al. GATA2 and secondary mutations in familial myelodysplastic syndromes and pediatric myeloid malignancies. Haematologica 100:10 (2015), E398–E401.
52. Zhang, M.Y., Keel, S.B., Walsh, T., et al. Genomic analysis of bone marrow failure and myelodysplastic syndromes reveals phenotypic and diagnostic complexity. Haematologica 100:1 (2015), 42–48.
53. Niimi, K., Kiyoi, H., Ishikawa, Y., et al. GATA2 zinc finger 2 mutation found in acute myeloid leukemia impairs myeloid differentiation. Leuk Res Rep 2:1 (2013), 21–25.
54. Cortes-Lavaud, X., Landecho, M.F., Maicas, M., et al. GATA2 Germline mutations impair GATA2 transcription, causing haploinsufficiency: functional analysis of the p.Arg396Gln mutation. J Immunol 194:5 (2015), 2190–2198.
55. Ping, N., Sun, A., Song, Y., et al. Exome sequencing identifies highly recurrent somatic GATA2 and CEBPA mutations in acute erythroid leukemia. Leukemia 31:1 (2017), 195–202.
56. Zhang, S.-J., Ma, L.-Y., Huang, Q.-H., et al. Gain-of-function mutation of GATA-2 in acute myeloid transformation of chronic myeloid leukemia. Proc Natl Acad Sci U S A 105:6 (2008), 2076–2081.
57. Hirabayashi, S., Niemeyer, C.M., Wlodarski, M.W., Unexpected high frequency of GATA2 mutations in children with non-familial MDS and monosomy 7. 54th ASH Annual Meeting and Exposition; Saturday, December 8, 2012. 2012, Blood, Atlanta, GA.
58. Micol, J.B., Abdel-Wahab, O., Collaborating constitutive and somatic genetic events in myeloid malignancies: ASXL1 mutations in patients with germline GATA2 mutations. Haematologica 99:2 (2014), 201–203.
59. Kozyra, E.J., Hirabayashi, S., Loyola, V.B.P., et al. Clonal mutational landscape of childhood myelodysplastic syndromes. Blood, 126(23), 2015.
60. Loyola, V.B.P., Hirabayashi, S., Pohl, S., et al. Somatic genetic and epigenetic architecture of myelodysplastic syndromes arising from GATA2 deficiency. Blood, 126(23), 2015.
61. Pastor, V., Hirabayashi, S., Karow, A., et al. Mutational landscape in children with myelodysplastic syndromes is distinct from adults: specific somatic drivers and novel germline variants. Leukemia 31:3 (2017), 759–762.
62. Makishima, H., Yoshida, K., Nguyen, N., et al. Somatic SETBP1 mutations in myeloid malignancies. Nat Genet 45:8 (2013), 942–946.
63. Piazza, R., Valletta, S., Winkelmann, N., et al. Recurrent SETBP1 mutations in atypical chronic myeloid leukemia. Nat Genet 45:1 (2013), 18–24.
64. Grossman, J., Cuellar-Rodriguez, J., Gea-Banacloche, J., et al. Nonmyeloablative allogeneic hematopoietic stem cell transplantation for GATA2 deficiency. Biol Blood Marrow Transplant 20:12 (2014), 1940–1948.
65. Cuellar-Rodriguez, J., Gea-Banacloche, J., Freeman, A.F., et al. Successful allogeneic hematopoietic stem cell transplantation for GATA2 deficiency. Blood 118:13 (2011), 3715–3720.
66. Cuellar-Rodriguez, J., Hickstein, D.D., Grossman, J.K., et al. Nonmyeloablative versus myeloablative allogeneic hematopoietic stem cell transplant for GATA2 deficiency. Blood, 124(21), 2014.
67. Hickstein, D.D., Shah, N.N., Freeman, A., Zerbe, C., Holland, S.M., Allogeneic hematopoietic stem cell transplant for GATA2 deficiency. Blood, 128(22), 2016.
68. Saida, S., Umeda, K., Yasumi, T., et al. Successful reduced-intensity stem cell transplantation for GATA2 deficiency before progression of advanced MDS. Pediatr Transplant 20:2 (2016), 333–336.
69. Churpek, J.E., Pyrtel, K., Kanchi, K.L., Shao, J., et al. Genomic analysis of germ line and somatic variants in familial myelodysplasia/acute myeloid leukemia. Blood(22), 2015, 2484–2490 http://dx.doi.org/10.1182/blood-2015-04-641100.
70. Strindhall, J., Skog, M., Ernerudh, J., et al. The inverted CD4/CD8 ratio and associated parameters in 66-year-old individuals: the Swedish HEXA immune study. Age (Dordr) 35:3 (2013), 985–991.